Sign In

Levent Selamoglu

Levent Selamoglu is the Chairperson of Afrigen Biologics (Pty) Ltd and has over 500 connections on LinkedIn.1 He is also associated with Zdravlje, a pharmaceutical company, and has been involved in several significant developments in the biopharmaceutical industry.

Professional Experience

Selamoglu has held leadership positions in multiple pharmaceutical companies:

  • Chairperson at Afrigen Biologics (Pty) Ltd1
  • CEO at MN Pharmaceuticals3

Recent Achievements

  • In July 2024, Selamoglu highlighted the high manufacturing quality standards maintained by his company.2
  • In August 2024, he announced that Zdravlje received certification from EcoVadis, a global provider of business sustainability ratings.4

Notable Business Developments

In September 2023, Selamoglu reported that Frontier Biopharma, the parent company of Zdravlje AD, signed a significant Memorandum of Understanding (MoU) with SK Bioscience and the Government of Serbia to establish a new venture.57

Education

Selamoglu attended Boğaziçi University.1

Additional Roles

As of January 2023, Selamoglu also served as an Executive Board Advisor & Consultant, focusing on international scaleup and go-to-market strategies.6

Related Questions

What is Levent Selamoglu's background before joining Zdravlje Leskovac?
How has Levent Selamoglu contributed to Zdravlje Leskovac's growth?
What are Levent Selamoglu's key achievements at Afrigen Biologics?
What is the significance of the MoU signed by Frontier Biopharma and SK Bioscience?
How does Levent Selamoglu's experience at MN Pharmaceuticals relate to his role at Zdravlje Leskovac?
Levent Selamoglu
Levent Selamoglu, photo 1
Levent Selamoglu, photo 2
Add to my network

Location

Turkey